268 related articles for article (PubMed ID: 32795188)
21. Survival benefit of induction immunosuppression in cystic fibrosis lung transplant recipients.
Kirkby S; Whitson BA; Wehr AM; Lehman AM; Higgins RS; Hayes D
J Cyst Fibros; 2015 Jan; 14(1):104-10. PubMed ID: 24948447
[TBL] [Abstract][Full Text] [Related]
22. Influence of graft ischemic time on survival in children with cystic fibrosis after lung transplantation.
Hayes D; Tumin D; Kopp BT; Tobias JD; Sheikh SI; Kirkby SE
Pediatr Pulmonol; 2016 Sep; 51(9):908-13. PubMed ID: 27129023
[TBL] [Abstract][Full Text] [Related]
23. Pre-transplant Panel Reactive Antibody and Survival in Adult Cystic Fibrosis Patients After Lung Transplantation.
Hayes D; Tumin D; Tobias JD
Lung; 2016 Jun; 194(3):429-35. PubMed ID: 26932810
[TBL] [Abstract][Full Text] [Related]
24. High-risk age window for mortality in children with cystic fibrosis after lung transplantation.
Hayes D; McCoy KS; Whitson BA; Mansour HM; Tobias JD
Pediatr Transplant; 2015 Mar; 19(2):206-10. PubMed ID: 25430504
[TBL] [Abstract][Full Text] [Related]
25. True survival benefit of lung transplantation for cystic fibrosis patients: the Zurich experience.
Hofer M; Benden C; Inci I; Schmid C; Irani S; Speich R; Weder W; Boehler A
J Heart Lung Transplant; 2009 Apr; 28(4):334-9. PubMed ID: 19332259
[TBL] [Abstract][Full Text] [Related]
26. Impaired Renal Function Should Not Be a Barrier to Transplantation in Patients With Cystic Fibrosis.
Crawford TC; Magruder JT; Grimm JC; Suarez-Pierre A; Zhou X; Ha JS; Higgins RS; Broderick SR; Orens JB; Shah P; Merlo CA; Kim BS; Bush EL
Ann Thorac Surg; 2017 Oct; 104(4):1231-1236. PubMed ID: 28822537
[TBL] [Abstract][Full Text] [Related]
27. Lung transplantation and gender effects on survival of recipients with cystic fibrosis.
Raghavan D; Gao A; Ahn C; Kaza V; Finklea J; Torres F; Jain R
J Heart Lung Transplant; 2016 Dec; 35(12):1487-1496. PubMed ID: 27469016
[TBL] [Abstract][Full Text] [Related]
28. Impact of burkholderia infection on lung transplantation in cystic fibrosis.
Murray S; Charbeneau J; Marshall BC; LiPuma JJ
Am J Respir Crit Care Med; 2008 Aug; 178(4):363-71. PubMed ID: 18535253
[TBL] [Abstract][Full Text] [Related]
29. Cystic fibrosis survival outcomes following second lung transplant: The north American experience.
Alshehri M; Ramos KJ; Sykes J; Ma X; Stanojevic S; Quon BS; Marshall BC; Cromwell E; Ostrenga JS; Faro A; Elbert A; Todd J; Chaparro C; Goss CH; Stephenson AL
Clin Transplant; 2023 Nov; 37(11):e15097. PubMed ID: 37563332
[TBL] [Abstract][Full Text] [Related]
30. The effect of the cystic fibrosis care center on outcomes after lung transplantation for cystic fibrosis.
Bush EL; Krishnan A; Chidi AP; Nolley E; Agbor-Enoh S; West NE; Tallarico E; Orens JB; Ha J; Shah PD; Ramos KJ; Segev D; Massie A; Higgins RS; Merlo CA
J Heart Lung Transplant; 2022 Mar; 41(3):300-307. PubMed ID: 34930671
[TBL] [Abstract][Full Text] [Related]
31. Clinical Characteristics and Predictors of Reduced Survival for Adult-diagnosed Cystic Fibrosis. Analysis of the Canadian CF Registry.
Desai S; Wong H; Sykes J; Stephenson AL; Singer J; Quon BS
Ann Am Thorac Soc; 2018 Oct; 15(10):1177-1185. PubMed ID: 29944384
[TBL] [Abstract][Full Text] [Related]
32. Outcomes in cystic fibrosis lung transplant recipients infected with organisms labeled as pan-resistant: An ISHLT Registry‒based analysis.
Lay C; Law N; Holm AM; Benden C; Aslam S
J Heart Lung Transplant; 2019 May; 38(5):545-552. PubMed ID: 30733155
[TBL] [Abstract][Full Text] [Related]
33. Increased risk of PTLD in lung transplant recipients with cystic fibrosis.
Lowery EM; Adams W; Grim SA; Clark NM; Edwards L; Layden JE
J Cyst Fibros; 2017 Nov; 16(6):727-734. PubMed ID: 28456611
[TBL] [Abstract][Full Text] [Related]
34. Use of lung transplantation survival models to refine patient selection in cystic fibrosis.
Liou TG; Adler FR; Huang D
Am J Respir Crit Care Med; 2005 May; 171(9):1053-9. PubMed ID: 15695493
[TBL] [Abstract][Full Text] [Related]
35. Reduced survival in adult cystic fibrosis despite attenuated lung function decline.
Keating C; Poor AD; Liu X; Chiuzan C; Backenroth D; Zhang Y; DiMango E
J Cyst Fibros; 2017 Jan; 16(1):78-84. PubMed ID: 27522311
[TBL] [Abstract][Full Text] [Related]
36. Bridging the survival gap in cystic fibrosis: An investigation of lung transplant outcomes in Canada and the United States.
Stephenson AL; Ramos KJ; Sykes J; Ma X; Stanojevic S; Quon BS; Marshall BC; Petren K; Ostrenga JS; Fink AK; Faro A; Elbert A; Chaparro C; Goss CH
J Heart Lung Transplant; 2021 Mar; 40(3):201-209. PubMed ID: 33386232
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of cystic fibrosis patients prior to lung transplantation: An international comparison between Canada and the United States.
Quon BS; Sykes J; Stanojevic S; Marshall BC; Petren K; Ostrenga J; Fink A; Elbert A; Faro A; Goss CH; Stephenson AL
Clin Transplant; 2018 Mar; 32(3):e13188. PubMed ID: 29292522
[TBL] [Abstract][Full Text] [Related]
38. No survival benefit to gaining private health insurance coverage for post-lung transplant care in adults with cystic fibrosis.
Tumin D; Foraker RE; Tobias JD; Hayes D
Clin Transplant; 2016 Mar; 30(3):320-7. PubMed ID: 26782769
[TBL] [Abstract][Full Text] [Related]
39. Body Mass Index Recovery after Lung Transplant for Cystic Fibrosis.
Pryor JB; Bradford MC; Jennerich AL; Wai TYH; Pilewski JM; Kapnadak SG; Aitken ML; Goss CH; Ramos KJ
Ann Am Thorac Soc; 2022 Jul; 19(7):1130-1138. PubMed ID: 35044894
[No Abstract] [Full Text] [Related]
40. Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections.
Lobo LJ; Chang LC; Esther CR; Gilligan PH; Tulu Z; Noone PG
Clin Transplant; 2013; 27(4):523-9. PubMed ID: 23710571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
